Wen-Feng Zhang Selected Research

Neoplasms (Cancer)

3/2021	Efficient Editing of an Adenoviral Vector Genome with CRISPR/Cas9.
10/2020	Overexpression of PREX1 in oral squamous cell carcinoma indicates poor prognosis.
1/2020	Long Non-coding RNA LINC02195 as a Regulator of MHC I Molecules and Favorable Prognostic Marker for Head and Neck Squamous Cell Carcinoma.
1/2020	Targeting CMTM6 Suppresses Stem Cell-Like Properties and Enhances Antitumor Immunity in Head and Neck Squamous Cell Carcinoma.
10/2019	Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma.
7/2019	High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma.
1/2019	Cancer Cell Membrane Camouflaged Nanoparticles to Realize Starvation Therapy Together with Checkpoint Blockades for Enhancing Cancer Therapy.
1/2019	Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway.
11/2018	Inhibition of SRC family kinases facilitates anti-CTLA4 immunotherapy in head and neck squamous cell carcinoma.
8/2018	Over-expression of IQGAP1 indicates poor prognosis in head and neck squamous cell carcinoma.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wen-Feng Zhang Research Topics

Disease

37	Neoplasms (Cancer) 03/2021 - 01/2006
37	Squamous Cell Carcinoma of Head and Neck 01/2020 - 01/2015
6	Neoplasm Metastasis (Metastasis) 06/2019 - 12/2008
6	Adenoid Cystic Carcinoma (Cylindroma) 09/2015 - 01/2012
5	Carcinogenesis 01/2020 - 12/2015
4	Inflammation (Inflammations) 01/2023 - 11/2016
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 12/2008
4	Hypoxia (Hypoxemia) 03/2016 - 01/2006
4	Hemangioma (Angioma) 05/2013 - 01/2007
3	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 02/2013
3	Pleomorphic Adenoma 01/2015 - 01/2014
2	Hypertension (High Blood Pressure) 07/2020 - 01/2020
2	Lymphatic Metastasis 01/2018 - 01/2016
2	Head and Neck Neoplasms (Head and Neck Cancer) 03/2017 - 01/2017
2	Carcinoma (Carcinomatosis) 09/2015 - 12/2008
2	Mouth Neoplasms (Oral Cancer) 10/2007 - 07/2006
1	Sepsis (Septicemia) 03/2024
1	Cough 02/2024
1	Oculocutaneous albinism type 2 04/2023
1	Virus Diseases (Viral Diseases) 03/2021
1	Coinfection 01/2020
1	COVID-19 01/2020
1	Anorexia 01/2020
1	Fatigue 01/2020
1	Fever (Fevers) 01/2020
1	Disease Progression 01/2020
1	Starvation 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 10/2020 - 07/2008
7	Transforming Growth Factor-beta Type I ReceptorIBA 11/2018 - 01/2015
6	Immune Checkpoint ProteinsIBA 10/2019 - 01/2016
6	SurvivinIBA 01/2017 - 02/2013
5	Monoclonal AntibodiesIBA 03/2018 - 01/2016
4	NSC 74859IBA 01/2017 - 12/2015
3	Biomarkers (Surrogate Marker)IBA 06/2019 - 01/2015
3	Cisplatin (Platino)FDA LinkGeneric 03/2016 - 04/2015
2	Oxygen (Dioxygen)IBA 02/2024 - 01/2020
2	Phosphotransferases (Kinase)IBA 01/2023 - 01/2020
2	Long Noncoding RNAIBA 01/2020 - 06/2019
2	MicroRNAs (MicroRNA)IBA 01/2019 - 05/2017
2	Dasatinib (BMS 354825)FDA Link 11/2018 - 03/2017
2	src-Family KinasesIBA 11/2018 - 03/2017
2	p21-Activated KinasesIBA 05/2018 - 01/2016
2	Folic Acid (Vitamin M)FDA LinkGeneric 03/2018 - 01/2017
2	Mucin-3IBA 03/2018 - 01/2017
2	Immunoglobulins (Immunoglobulin)IBA 03/2018 - 01/2017
2	InflammasomesIBA 01/2018 - 01/2017
2	Fluorouracil (Carac)FDA LinkGeneric 03/2016 - 12/2015
2	Cetuximab (Erbitux)FDA Link 03/2016 - 01/2015
2	Docetaxel (Taxotere)FDA Link 03/2016 - 12/2015
2	ErbB Receptors (EGF Receptor)IBA 09/2015 - 01/2015
2	Cyclin D1IBA 04/2015 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2008 - 01/2006
1	RNA (Ribonucleic Acid)IBA 03/2024
1	Angiogenesis InhibitorsIBA 11/2023
1	Immune Checkpoint InhibitorsIBA 11/2023
1	Melanins (Melanin)IBA 04/2023
1	2,2',4,4'-tetrabromodiphenyl etherIBA 04/2023
1	Monophenol Monooxygenase (Tyrosinase)IBA 04/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2020
1	C-Reactive ProteinIBA 07/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2020
1	lactate dehydrogenase C4IBA 01/2020
1	CateninsIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	AlbuminsIBA 01/2020
1	NitrogenIBA 01/2020
1	Small Interfering RNA (siRNA)IBA 01/2020
1	CreatinineIBA 01/2020
1	EnzymesIBA 01/2020
1	Histocompatibility Antigens Class IIBA 01/2020
1	Urea (Carbamide)FDA LinkGeneric 01/2020
1	Therapeutic UsesIBA 10/2019
1	IgA receptor (protein B)IBA 07/2019
1	Glycoproteins (Glycoprotein)IBA 07/2019
1	leukocyte-associated immunoglobulin-like receptor 1IBA 01/2019
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2019
1	Glucose OxidaseIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Circular RNAIBA 01/2019
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 08/2018
1	PhosphoproteinsIBA 05/2018
1	Galectins (Galectin)IBA 03/2018
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2018
1	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	AntibodiesIBA 01/2018
1	GoldIBA 01/2018
1	InterleukinsIBA 01/2018
1	Serine (L-Serine)FDA Link 01/2018
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2018

Therapy/Procedure

11	Therapeutics 11/2023 - 01/2007
9	Immunotherapy 03/2021 - 12/2015
6	Drug Therapy (Chemotherapy) 09/2016 - 01/2012
2	Radiotherapy 04/2015 - 01/2015
2	Myocutaneous Flap 10/2007 - 07/2006
1	Photothermal Therapy 01/2018
1	Lasers (Laser) 01/2018